Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Can placebo therapy influence arterial blood pressure?

Gould BA, Mann S, Davies AB, Altman DG, Raftery EB.

Clin Sci (Lond). 1981 Dec;61 Suppl 7:487s-490s.

PMID:
7318355
2.

Does placebo lower blood-pressure?

Gould BA, Mann S, Davies AB, Altman DG, Raftery EB.

Lancet. 1981 Dec 19-26;2(8260-61):1377-81.

PMID:
6118757
3.

The effect of placebo on indirect and direct blood pressure measurements.

Raftery EB, Gould BA.

J Hypertens Suppl. 1990 Dec;8(6):S93-100.

PMID:
2082005
4.

The effect of indoramin on exercise performance in mild hypertension.

Bishop N, Mackintosh AF, Stoker JB, Mary DA, Linden RJ.

J Cardiovasc Pharmacol. 1986;8 Suppl 2:S30-6.

PMID:
2423794
5.

A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.

Antani J, Buckle JW, Turner J, Cohen M.

Curr Med Res Opin. 1983;8(9):603-11.

PMID:
6365463
6.

Indoramin in the treatment of hypertension: a placebo controlled trial.

Ramirez J.

Curr Med Res Opin. 1976;4(3):177-84.

PMID:
780059
8.

Alpha-adrenoreceptor blockade with indoramin in hypertension.

Gould BA, Mann S, Davies AB, Altman DG, Raftery EB.

J Cardiovasc Pharmacol. 1983 May-Jun;5(3):343-8.

PMID:
6191130
9.

[Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].

Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.

Arch Mal Coeur Vaiss. 2001 Aug;94(8):907-12. French.

PMID:
11575229
10.

Effect of indoramin on finger circulation in patients with Raynaud disease.

Clement DL, Duprez D, De Pue N.

J Cardiovasc Pharmacol. 1986;8 Suppl 2:S84-7.

PMID:
2423806
12.
13.

Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.

Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ.

Pediatr Nephrol. 2002 May;17(5):345-50.

PMID:
12042891
15.

Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study.

Hsieh MH, Chan P, Sue YM, Liu JC, Liang TH, Huang TY, Tomlinson B, Chow MS, Kao PF, Chen YJ.

Clin Ther. 2003 Nov;25(11):2797-808.

PMID:
14693305
19.

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A; FEVER Study Group.

J Hypertens. 2005 Dec;23(12):2157-72.

PMID:
16269957

Supplemental Content

Support Center